Avid Bioservices Inc, a biologics contract development and manufacturing organization (CDMO), announced on Tuesday the opening of its new Early Phase Center of Excellence in Costa Mesa, California.

The 78,000 sq ft facility is purpose built to support early clinical programs. It expands Avid's development footprint and strengthens the company's ability to provide end-to-end services from cell line development to commercial manufacturing.

Designed to accelerate clients' early development timelines, the facility brings together Avid's core scientific and technical capabilities including cell line development; upstream and downstream process and analytical development; IND enabling analytical method qualification, and testing; early formulation development and characterization; and integrated tech transfer into the company's CGMP manufacturing facilities.

The Costa Mesa expansion enhances Avid's overall capacity to support a wide range of biologics including monoclonal antibodies, recombinant proteins, and other complex modalities.